UCSF 40th Annual Symposium Cardiology for the Practitioner
October 19 - 21, 2026 - CA USUniversity of California Office of CME
dawn.bohlmann@ucsf.edu
Phone:415-476-6127
This three-day symposium is an intensive course designed for internists, primary care physicians, family practitioners, cardiologists, and other healthcare providers who encounter patients with various heart diseases. This year's program will focus on the review of the recent ACC/AHA Practice Guidelines for Hypertension, Heart failure, Lipids and Diabetes. Additionally, there will be special sessions on the impact and utility of Artificial Intelligence (AI) in the diagnosis and management of various cardiac disorders. These discussions will include the use of various wearable devices for detection and management of common cardiac conditions. There will also be emphasis on current and emerging therapies for various lipid disorders, diabetes, common cardiac arrhythmias and Structural heart disorders, as well as heart disease in Women. During the symposium these topics will be discussed in detail with special emphasis on the recent advances in pathophysiology, therapeutic considerations, and clinical relevance of recent drug developments for cardiovascular disorders. Emphasis will be placed on the recent practice guidelines and updates for common cardiovascular conditions. The entire course will focus on frequently encountered clinical problems in cardiac patients by practicing physicians. There will be state-of-the-art and comprehensive reviews on the evaluation and management of coronary risk factors, hypertension, hyperlipidemia, diabetes, and coronary artery disease, atrial fibrillation, valvular heart disease. Special focus will be placed on review of traditional and emerging cardiac risk factors highlighting primary and secondary prevention strategies. In addition, we will discuss updates and critical review of newer diagnostic imaging modalities, use of newer therapeutic strategies based on recent clinical trials, and emerging interventional techniques for CVD. Lastly, topics will be discussed pertaining to reviews on recent clinical trials and practice guidelines in the management of hypertension, dyslipidemia, atrial fibrillation, valvular heart disease, the role of various wearable devices as well as device therapies in cardiac arrhythmias and HF. Time: 8:00 am to 1:30 pm